Women with symptoms are more likely to report being less able to work and prolonged absences. In an editorial, two physicians say that the effect of menopause on clinicians is too little discussed.
Combination therapy with relugolix (Orgovyx, Relumina), a gonadotropin-releasing hormone antagonist, significantly reduced the pain of uterine fibroids in a new study.
The issue is significant, as regular menstruation is a sign of health and fertility, and fears of disturbances might increase vaccination hesitancy as COVID-19 cases continue to surge.